1 Maximum percent decrease in FEV‐1 |
7 |
194 |
Mean Difference (IV, Random, 95% CI) |
‐0.88 [‐4.49, 2.74] |
1.1 children |
5 |
138 |
Mean Difference (IV, Random, 95% CI) |
‐0.18 [‐4.38, 4.01] |
1.2 adults/combined |
2 |
56 |
Mean Difference (IV, Random, 95% CI) |
‐2.96 [‐13.21, 7.29] |
2 Failure to achieve Complete Protection: Maximum % fall >10% |
6 |
156 |
Odds Ratio (M‐H, Random, 95% CI) |
0.95 [0.50, 1.81] |
2.1 Children |
4 |
100 |
Odds Ratio (M‐H, Random, 95% CI) |
0.85 [0.39, 1.88] |
2.2 Adults/combination |
2 |
56 |
Odds Ratio (M‐H, Random, 95% CI) |
1.17 [0.38, 3.63] |
3 Failure to achieve Complete Protection: Maximum % fall >15% |
6 |
170 |
Odds Ratio (M‐H, Random, 95% CI) |
0.69 [0.33, 1.47] |
3.1 Children |
5 |
138 |
Odds Ratio (M‐H, Random, 95% CI) |
0.89 [0.44, 1.81] |
3.2 Adults/combination |
1 |
32 |
Odds Ratio (M‐H, Random, 95% CI) |
0.2 [0.04, 0.91] |
4 Failure to achieve Clinical Protection: <50% improvement over placebo |
6 |
156 |
Odds Ratio (M‐H, Random, 95% CI) |
0.71 [0.36, 1.39] |
4.1 Children |
4 |
100 |
Odds Ratio (M‐H, Random, 95% CI) |
0.76 [0.32, 1.79] |
4.2 Adults/combination |
2 |
56 |
Odds Ratio (M‐H, Random, 95% CI) |
0.65 [0.22, 1.88] |
5 Side Effects |
3 |
|
Odds Ratio (M‐H, Random, 95% CI) |
Subtotals only |
5.1 unpleasant taste |
3 |
94 |
Odds Ratio (M‐H, Random, 95% CI) |
6.85 [0.77, 60.73] |
5.2 sore throat |
2 |
56 |
Odds Ratio (M‐H, Random, 95% CI) |
3.46 [0.32, 37.47] |